E-LIB Suche - Ergebnisse für: Gori, Viviana

1

Multimodal treatment with curative intent in a germline BRC..:

Mauri, Gianluca ; Gori, Viviana ; Patelli, Giorgio...
World Journal of Surgical Oncology. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

2

Corrigendum: Case report: MAP2K1 K57N mutation is associate..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Case Report: MAP2K1 K57N mutation is associated with primar..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

4

Efficacy of Retreatment with Oxaliplatin-Based Regimens in ..:

Amatu, Alessio ; Mauri, Gianluca ; Tosi, Federica...
Cancers. 14 (2022) 5 - p. 1197 , 2022

Link: https://doi.org/10.3390/..

5

The Evolutionary Landscape of Treatment for BRAFV600E Mutan..:

Mauri, Gianluca ; Bonazzina, Erica ; Amatu, Alessio...
Cancers. 13 (2021) 1 - p. 137 , 2021

Link: https://doi.org/10.3390/..

6

Oxaliplatin retreatment in metastatic colorectal cancer: Sy..:

Mauri, Gianluca ; Gori, Viviana ; Bonazzina, Erica...
Cancer Treatment Reviews. 91 (2020) - p. 102112 , 2020

Link: https://doi.org/10.1016/..

7

Multimodal treatment with curative intent in a germline BRC..:

Mauri, Gianluca ; Gori, Viviana ; Patelli, Giorgio...
info:eu-repo/semantics/altIdentifier/pmid/36998040. , 2023

Link: https://hdl.handle.net/2..

8

Corrigendum: Case report: MAP2K1 K57N mutation is associate..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086435/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Case Report: MAP2K1 K57N mutation is associated with primar..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
info:eu-repo/semantics/altIdentifier/pmid/36419886. , 2022

Link: https://hdl.handle.net/2..

10

Case Report: MAP2K1 K57N mutation is associated with primar..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
info:eu-repo/semantics/altIdentifier/pmid/36419886. , 2022

Link: https://hdl.handle.net/2..

11

Efficacy of Retreatment with Oxaliplatin-Based Regimens in ..:

Amatu, Alessio ; Mauri, Gianluca ; Tosi, Federica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909235/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Case Report: MAP2K1 K57N mutation is associated with primar..:

Mauri, Gianluca ; Patelli, Giorgio ; Gori, Viviana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676472/. , 2022

Link: http://www.ncbi.nlm.nih...

13

The Evolutionary Landscape of Treatment for BRAF(V600E) Mut..:

Mauri, Gianluca ; Bonazzina, Erica ; Amatu, Alessio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795863/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Multimodal treatment with curative intent in a germline BRC..:

Gianluca Mauri ; Viviana Gori ; Giorgio Patelli...
https://doi.org/10.1186/s12957-023-02976-0. , 2023

Link: https://doi.org/10.1186/..

15

Corrigendum: Case report: MAP2K1 K57N mutation is associate..:

Gianluca Mauri ; Giorgio Patelli ; Viviana Gori...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1147497/full. , 2023

Link: https://doi.org/10.3389/..